These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 1683852

  • 1. Intravenous administration of lisuride in the treatment of neuroleptic malignant syndrome.
    de Mari M, Lamberti P, Simone F, Iliceto G, Federico F, Ferrari E.
    Funct Neurol; 1991; 6(3):285-8. PubMed ID: 1683852
    [Abstract] [Full Text] [Related]

  • 2. Intravenous lisuride in the treatment of the neuroleptic malignant syndrome.
    Sczesni B, Bittkau S, von Baumgarten F, von Schröder J, Suchy I, Przuntek H.
    J Clin Psychopharmacol; 1991 Jun; 11(3):185-8. PubMed ID: 2066456
    [Abstract] [Full Text] [Related]

  • 3. Neuroleptic malignant syndrome treated with subcutaneous lisuride infusion.
    Rodriguez ME, Luquin MR, Lera G, Delgado G, Salazar JM, Obeso JA.
    Mov Disord; 1990 Jun; 5(2):170-2. PubMed ID: 2325680
    [Abstract] [Full Text] [Related]

  • 4. [Diagnostic and therapeutic aspects of neuroleptic malignant syndrome based on 12 cases].
    Sczesni B, Becker H, Schröder J, Bittkau S, von Baumgarten F, Truong DD, Przuntek H.
    Wien Klin Wochenschr; 1991 Jun; 103(1):21-6. PubMed ID: 1673042
    [No Abstract] [Full Text] [Related]

  • 5. Neuroleptic malignant syndrome induced by ziprasidone on the second day of treatment.
    Ozen ME, Yumru M, Savas HA, Cansel N, Herken H.
    World J Biol Psychiatry; 2007 Jun; 8(1):42-4. PubMed ID: 17366349
    [Abstract] [Full Text] [Related]

  • 6. [Neuroleptic malignant syndrome and atypical antipsychotics: a brief review].
    Khaldi S, Kornreich C, Choubani Z, Gourevitch R.
    Encephale; 2008 Dec; 34(6):618-24. PubMed ID: 19081460
    [Abstract] [Full Text] [Related]

  • 7. [Neuroleptic malignant syndrome].
    Murak E.
    Psychiatr Pol; 1995 Dec; 29(3):349-58. PubMed ID: 7652088
    [Abstract] [Full Text] [Related]

  • 8. Neuroleptic malignant syndrome in traumatic brain injury patients treated with haloperidol.
    Bellamy CJ, Kane-Gill SL, Falcione BA, Seybert AL.
    J Trauma; 2009 Mar; 66(3):954-8. PubMed ID: 19276778
    [Abstract] [Full Text] [Related]

  • 9. [Neuroleptic malignant syndrome].
    Sczesni B, Schröder J, Becker H, Przuntek H.
    Wien Klin Wochenschr; 1991 Mar; 103(1):1-7. PubMed ID: 1673041
    [Abstract] [Full Text] [Related]

  • 10. Successful treatment of a complicated case of neuroleptic malignant syndrome.
    Lappa A, Podestà M, Capelli O, Castagna A, Di Placido G, Alampi D, Semeraro F.
    Intensive Care Med; 2002 Jul; 28(7):976-7. PubMed ID: 12122539
    [Abstract] [Full Text] [Related]

  • 11. Treatment of neuroleptic malignant syndrome with dopamine hydrochloride: a case report.
    Ungvari GA.
    Pharmacopsychiatry; 1987 May; 20(3):120-1. PubMed ID: 2885866
    [Abstract] [Full Text] [Related]

  • 12. Neuroleptic malignant syndrome: life-threatening complication of neuroleptic treatment in adolescents with affective disorder.
    Joshi PT, Capozzoli JA, Coyle JT.
    Pediatrics; 1991 Feb; 87(2):235-9. PubMed ID: 1670966
    [Abstract] [Full Text] [Related]

  • 13. [Pathophysiology and therapy of malignant neuroleptic syndrome].
    Weller M, Kornhuber J.
    Nervenarzt; 1992 Nov; 63(11):645-55. PubMed ID: 1361662
    [Abstract] [Full Text] [Related]

  • 14. [Studies of risk factors and preventive care for neuroleptic malignant syndrome].
    Tanii H.
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2006 Nov; 26(5-6):177-81. PubMed ID: 17240842
    [Abstract] [Full Text] [Related]

  • 15. Catatonic variants, hyperthermic extrapyramidal reactions, and subtypes of neuroleptic malignant syndrome.
    Lee JW.
    Ann Clin Psychiatry; 2007 Nov; 19(1):9-16. PubMed ID: 17453656
    [Abstract] [Full Text] [Related]

  • 16. [Differential diagnosis of acute life threatening catatonia and malignant neuroleptic syndrome--a case report].
    Hermle L, Oepen G.
    Fortschr Neurol Psychiatr; 1986 Jun; 54(6):189-95. PubMed ID: 2873091
    [Abstract] [Full Text] [Related]

  • 17. Electroconvulsive therapy for the treatment of neuroleptic malignant syndrome with psychotic symptoms: a report of five cases.
    Nisijima K, Ishiguro T.
    J ECT; 1999 Jun; 15(2):158-63. PubMed ID: 10378156
    [Abstract] [Full Text] [Related]

  • 18. Neuroleptic malignant syndrome: a preventive program.
    Fernando ML, Manchanda R, Kirk C.
    J Psychiatry Neurosci; 1992 Mar; 17(1):31-3. PubMed ID: 1349827
    [Abstract] [Full Text] [Related]

  • 19. Catatonia and neuroleptic malignant syndrome: two sides of a coin?
    Vancaester E, Santens P.
    Acta Neurol Belg; 2007 Jun; 107(2):47-50. PubMed ID: 17710840
    [Abstract] [Full Text] [Related]

  • 20. [Neuroleptic malignant syndrome].
    Dahm JB, Trenckmann U.
    Med Klin (Munich); 1991 Nov 15; 86(11):601-4. PubMed ID: 1685215
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.